Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates
Open Access
- 11 July 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 220 (9), 1462-1468
- https://doi.org/10.1093/infdis/jiz345
Abstract
The plaque reduction neutralization test (PRNT), which measures a subset of immunoglobulin antibodies (functional neutralizing antibodies), and the enzyme-linked immunosorbent assay (ELISA), which measures total immunoglobulin (neutralizing and nonneutralizing antibodies), characterize different aspects of the anti–mumps virus antibody response after vaccination. Data from a recent phase 3 clinical trial (NCT01681992) of 2 measles-mumps-rubella vaccines were used to compare anti-mumps antibody responses measured using an unenhanced PRNT (GSK; seropositivity cutoff and threshold, 2.5 and 4 times the 50% end-point dilution, respectively) with those estimated using an ELISA (thresholds, 5 and 10 ELISA units/mL, respectively). Of 3990 initially seronegative samples, 3284 (82.3%) were seropositive after vaccination for anti-mumps antibodies in both assays. The Pearson correlation coefficient for double-positive samples was 0.57, indicative of a moderate correlation. Receiver operating characteristic curve analysis showed that an ELISA threshold of 51.7 ELISA units/mL best corresponded to the PRNT seroresponse threshold. There was no obvious vaccine brand effect on the correlation between assays. The moderate correlation between the anti-mumps antibody measurements obtained with PRNT and ELISA reflects different aspects of the serological response. In the absence of a well-defined protective serological threshold, PRNT provides complementary information on the antibody response, whereas ELISA remains a critically useful measurement of vaccine immunogenicity.Keywords
Funding Information
- GlaxoSmithKline Biologicals
This publication has 22 references indexed in Scilit:
- A New Method for the Detection of Neutralizing Antibodies against Mumps VirusPLOS ONE, 2013
- Mumps Antibody Levels Among Students Before a Mumps Outbreak: In Search of a Correlate of ImmunityThe Journal of Infectious Diseases, 2011
- Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?European Journal of Clinical Microbiology & Infectious Diseases, 2011
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?Clinical Infectious Diseases, 2008
- Antibody Induced by Immunization with the Jeryl Lynn Mumps Vaccine Strain Effectively Neutralizes a Heterologous Wild‐Type Mumps Virus Associated with a Large OutbreakThe Journal of Infectious Diseases, 2008
- Long‐Term Persistence of Mumps Antibody after Receipt of 2 Measles‐Mumps‐Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University PopulationThe Journal of Infectious Diseases, 2008
- Mumps Virus-Specific Antibody Titers from Pre-Vaccine Era Sera: Comparison of the Plaque Reduction Neutralization Assay and Enzyme ImmunoassaysJournal of Clinical Microbiology, 2005
- Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virusBiologicals, 1990
- Vergleich von fünf verschiedenen Bestimmungsmethoden für MumpsantikörperInfection, 1980